CT
REGN icon

Coastline Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

Coastline Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1
Closed -$712 – 421
2024
Q4 		$712 Buy
+1
New +$839 ﹤0.01% 424
2023
Q2 		– Sell
-340
Closed -$279K – 294
2023
Q1 		$279K Hold
340
– – 0.04% 257
2022
Q4 		$245K Buy
+340
New +$251K 0.04% 261

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Coastline Trust's REGN Position: Q1 2025 in Review

Coastline Trust sold out of Regeneron Pharmaceuticals (REGN) in Q1 2025, closing a stake of 1 share — an estimated $712 sold.

Coastline Trust first reported a position in REGN in Q4 2022 and held it in 3 quarters. The position peaked at $279K in Q1 2023. 1,292 funds tracked by Wall St. Rank hold REGN as of Q1 2025.

  • Coastline Trust reported no remaining Regeneron Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Coastline Trust sold 1 Regeneron Pharmaceuticals share in Q1 2025, an estimated $712.
  • Coastline Trust first reported a position in Regeneron Pharmaceuticals in Q4 2022 and held it in 3 quarters.
  • Coastline Trust's Regeneron Pharmaceuticals position peaked at $279K in Q1 2023.
  • 1,292 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2025.

Based on Coastline Trust's 13F filing for Q1 2025, filed 28 Apr 2025.